1117. Tazobactam Pharmacokinetic/Pharmacodynamic Target Attainment in Healthy Volunteers and Critically-Ill Hospitalized Patients

BACKGROUND: Pharmacokinetic/pharmacodynamic (PK/PD) targets and attainment are well described for beta-lactams; however, are rarely considered for beta-lactamase inhibitors. Recent evidence suggests that tazobactam (TAZ) target exposures to restore piperacillin bacteriostatic and 1 log 10 bactericid...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalaria, Shamir N, Pogue, Jason M, Heil, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643785/
http://dx.doi.org/10.1093/ofid/ofab466.1310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643785/
http://dx.doi.org/10.1093/ofid/ofab466.1310

Ejemplares similares